Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Interest & Investment Income (2018 - 2025)

Neurogene's Interest & Investment Income history spans 6 years, with the latest figure at $2.7 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 17.75% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $11.5 million, up 36.36%, while the annual FY2025 figure was $11.5 million, 36.38% up from the prior year.
  • Interest & Investment Income reached $2.7 million in Q4 2025 per NGNE's latest filing, down from $2.7 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $3.2 million in Q1 2025 to a low of $650000.0 in Q3 2023.
  • Average Interest & Investment Income over 3 years is $1.9 million, with a median of $2.2 million recorded in 2024.
  • Peak YoY movement for Interest & Investment Income: surged 198.58% in 2024, then grew 17.75% in 2025.
  • A 3-year view of Interest & Investment Income shows it stood at $781000.0 in 2023, then surged by 190.65% to $2.3 million in 2024, then grew by 17.75% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Interest & Investment Income are $2.7 million (Q4 2025), $2.7 million (Q3 2025), and $2.9 million (Q2 2025).